These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 1739289

  • 41. Xeroderma Pigmentosum - Facts and Perspectives.
    Lehmann J, Seebode C, Martens MC, Emmert S.
    Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
    [Abstract] [Full Text] [Related]

  • 42. Colony-forming ability of ultraviolet-irradiated xeroderma pigmentosum fibroblasts from different DNA repair complementation groups.
    Kraemer KH, Andrews AD, Barrett SF, Robbins JH.
    Biochim Biophys Acta; 1976 Aug 18; 442(2):147-53. PubMed ID: 953007
    [Abstract] [Full Text] [Related]

  • 43. Screening for deficits in DNA repair by the response of irradiated human lymphocytes to phytohemagglutinin.
    Agarwal SS, Brown DQ, Katz EJ, Loeb LA.
    Cancer Res; 1977 Oct 18; 37(10):3594-8. PubMed ID: 908009
    [Abstract] [Full Text] [Related]

  • 44. Dose response and time course for induction of T6- DR+ human epidermal antigen-presenting cells by in vivo ultraviolet A, B, and C irradiation.
    Baadsgaard O, Cooper KD, Lisby S, Wulf HC, Wantzin GL.
    J Am Acad Dermatol; 1987 Nov 18; 17(5 Pt 1):792-800. PubMed ID: 3500191
    [Abstract] [Full Text] [Related]

  • 45. Significance of repair of human DNA: evidence from studies of xeroderma pigmentosum.
    Robbins JH.
    J Natl Cancer Inst; 1978 Sep 18; 61(3):645-56. PubMed ID: 278844
    [No Abstract] [Full Text] [Related]

  • 46. Reinvestigation of the classification of five cell strains of xeroderma pigmentosum group E with reclassification of three of them.
    Itoh T, Linn S, Ono T, Yamaizumi M.
    J Invest Dermatol; 2000 May 18; 114(5):1022-9. PubMed ID: 10771487
    [Abstract] [Full Text] [Related]

  • 47. The role of epidermal Langerhans cells in NB-UVB-induced immunosuppression.
    Taguchi K, Fukunaga A, Ogura K, Nishigori C.
    Kobe J Med Sci; 2013 Apr 09; 59(1):E1-9. PubMed ID: 23756657
    [Abstract] [Full Text] [Related]

  • 48. Sunlight damage to cellular DNA: Focus on oxidatively generated lesions.
    Schuch AP, Moreno NC, Schuch NJ, Menck CFM, Garcia CCM.
    Free Radic Biol Med; 2017 Jun 09; 107():110-124. PubMed ID: 28109890
    [Abstract] [Full Text] [Related]

  • 49. Protective Effect of Diphlorethohydroxycarmalol against Ultraviolet B Radiation-Induced DNA Damage by Inducing the Nucleotide Excision Repair System in HaCaT Human Keratinocytes.
    Piao MJ, Hewage SR, Han X, Kang KA, Kang HK, Lee NH, Hyun JW.
    Mar Drugs; 2015 Sep 02; 13(9):5629-41. PubMed ID: 26404324
    [Abstract] [Full Text] [Related]

  • 50. Clinical, cellular, and molecular features of an Israeli xeroderma pigmentosum family with a frameshift mutation in the XPC gene: sun protection prolongs life.
    Slor H, Batko S, Khan SG, Sobe T, Emmert S, Khadavi A, Frumkin A, Busch DB, Albert RB, Kraemer KH.
    J Invest Dermatol; 2000 Dec 02; 115(6):974-80. PubMed ID: 11121128
    [Abstract] [Full Text] [Related]

  • 51. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L, Wood NH, Motswaledi MH, Khammissa RA, Meyer M, Lemmer J.
    J Prev Med Hyg; 2010 Jun 02; 51(2):87-91. PubMed ID: 21155411
    [Abstract] [Full Text] [Related]

  • 52. Repair of 254 nm ultraviolet-induced (6-4) photoproducts: monoclonal antibody recognition and differential defects in xeroderma pigmentosum complementation groups A, D, and variant.
    Hiramoto T, Matsunaga T, Ichihashi M, Nikaido O, Fujiwara Y, Mishima Y.
    J Invest Dermatol; 1989 Nov 02; 93(5):703-6. PubMed ID: 2794553
    [Abstract] [Full Text] [Related]

  • 53. Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells.
    Yin Z, Xu J, Zhang Z, Luo D.
    Int Immunopharmacol; 2012 Dec 02; 14(4):635-40. PubMed ID: 23079131
    [Abstract] [Full Text] [Related]

  • 54. [Effects of UV irradiation on the human cells: mechanisms of repair in normal individuals and in individuals with xeroderma pigmentosum].
    Nuzzo-de Carli F.
    Pathologica; 1975 Dec 02; 67(967-968):175-86. PubMed ID: 1219578
    [No Abstract] [Full Text] [Related]

  • 55. Inhibition of DNA excision repair in human cells by arabinofuranosyl cytosine: effect on normal and xeroderma pigmentosum cells.
    Dunn WC, Regan JD.
    Mol Pharmacol; 1979 Mar 02; 15(2):367-74. PubMed ID: 470933
    [No Abstract] [Full Text] [Related]

  • 56. [Experimental study on dose effect relationships between ultraviolet rays and its early impairment].
    Tai SP.
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 May 02; 26(3):141-3. PubMed ID: 1395953
    [Abstract] [Full Text] [Related]

  • 57. Xeroderma pigmentosum complementation group G--report of two cases.
    Norris PG, Hawk JL, Avery JA, Giannelli F.
    Br J Dermatol; 1987 Jun 02; 116(6):861-6. PubMed ID: 3620347
    [Abstract] [Full Text] [Related]

  • 58. Effects of ultraviolet radiation on murine epidermal Langerhans cells: doses of ultraviolet radiation that modulate ICAM-1 (CD54) expression and inhibit Langerhans cell function cause delayed cytotoxicity in vitro.
    Tang A, Udey MC.
    J Invest Dermatol; 1992 Jul 02; 99(1):83-9. PubMed ID: 1351507
    [Abstract] [Full Text] [Related]

  • 59. Pigmented Xerodermoid: first report of a family.
    Hofmann H, Jung EG, Schnyder UW.
    Bull Cancer; 1978 Jul 02; 65(3):347-50. PubMed ID: 719186
    [Abstract] [Full Text] [Related]

  • 60. Novel therapeutic approaches to xeroderma pigmentosum.
    Weon JL, Glass DA.
    Br J Dermatol; 2019 Aug 02; 181(2):249-255. PubMed ID: 30265743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.